Antiviral drug Molnupiravir, earlier failed to convince the ICMR for its inclusion in India's national Covid-19 treatment protocol due to "safety concerns", even as it received an emergency use authorisation (EUA) from the country's drug regulator.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/EmN7pao
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» No merit seen in including Paxlovid in Covid treatment: ICMR
https://ift.tt/l1gQMqk
No comments:
Post a Comment